[EN] PYRAZOLYL-UREAS AS KINASE INHIBITORS<br/>[FR] PYRAZOLYL-URÉES UTILISÉES COMME INHIBITEURS DE KINASE
申请人:RESPIVERT LTD
公开号:WO2014027209A1
公开(公告)日:2014-02-20
There are provided compounds of formula I, wherein R, R1, Ra, Rb, Q, X and Y have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases) and have use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.
提供了具有式I的化合物,其中R、R1、Ra、Rb、Q、X和Y的含义如描述中所给,这些化合物具有抗炎活性(例如通过抑制p38丝裂原激活蛋白激酶家族中的一个或多个成员;Syk激酶;以及酪氨酸激酶Src家族的成员之一),并且在治疗中发挥作用,包括在制药组合中,特别是在治疗炎症性疾病方面,包括肺部、眼睛和肠道的炎症性疾病。